The 2014 Protecting Access to Medicare Act included a provision requiring clinicians consult with appropriate use criteria (AUC) through a qualified clinical decision support mechanism (CDSM) when ordering advanced imaging services (i.e., SPECT/PET MPI, CT and MR) in order to receive payment approval from the Centers for Medicare and Medicaid Services (CMS). Following several delays, the implementation of this requirement started Jan. 1, 2020. ACC is working to educate and prepare providers for the implementation of potentially significant changes to practice workflows resulting from the AUC Program.

Key Takeaways:

  • Jan. 1, 2020, marked the beginning of required reporting. However, this first year is an educational year during which CMS will not deny claims that incorrectly report AUC information.
  • Only entities meeting qualified "provider-led entity" standards, like the ACC, can develop AUC for use in the program.
  • AUC consultation through a CDSM has been designated as an Improvement Activity under the Merit-Based Incentive Payment System, part of the Quality Payment Program.
  • Key provisions include:
    • Healthcare Common Procedure Coding System G-codes and modifiers must be used to report required AUC information on Medicare claims for both the technical and professional components;
    • AUC consultation with a qualified CDSM can be delegated to clinical staff working under the direction of the ordering professional;
    • Insufficient internet access, electronic health record or CDSM vendor issues, or extreme and uncontrollable circumstances are eligible “Significant Hardship Criteria.”
  • The ACC continues to license its AUC content to qualified CDSM vendors. View a full list of ACC's CDSM partners. Access ACC’s licensing FAQ document.
  • Cardiovascular professionals should be holding planning discussions with their practice, cardiovascular business line and health systems to understand which AUC content and decision support vendors are, or will be, used.

Additional Resources: